The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity
Open accessAbstract
Huntington's disease (HD) is a neurodegenerative disorder caused by a polyglutamine (polyQ) tract expansion near the N terminus of huntingtin (Htt). Proteolytic processing of mutant Htt and abnormal calcium signaling may play a critical role in disease progression and pathogenesis. Recent work indicates that calpains may participate in the increased and/or altered patterns of Htt proteolysis leading to the selective toxicity observed in HD striatum. Here, we identify two calpain cleavage sites in Htt and show that mutation of these sites renders the polyQ expanded Htt less susceptible to proteolysis and aggregation, resulting in decreased toxicity in an in vitro cell culture model. In addition, we found that calpain- and caspase-derived Htt fragments preferentially accumulate in the nucleus without the requirement of further cleavage into smaller fragments. Calpain family members, calpain-1, -5, -7, and -10, have increased levels or are activated in HD tissue culture and transgenic mouse models, suggesting they may play a key role in Htt proteolysis and disease pathology. Interestingly, calpain-1, -5, -7, and -10 localize to the cytoplasm and the nucleus, whereas the activated forms of calpain-7 and -10 are found only in the nucleus. These results support the role of calpain-derived Htt fragmentation in HD and suggest that aberrant activation of calpains may play a role in HD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Yuan, J. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,483
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Cross-Talk between Two Cysteine Protease Families
Nakagawa, T., & Yuan, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.887 · Cited by 1,168
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Self-citationAtaxin-1 Nuclear Localization and Aggregation
Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y., & Orr, H. T. (1998) · Cell · doi:10.1016/s0092-8674(00)81781-x · Cited by 956
Calpain and caspase: can you tell the difference?
Wang, K. K. W. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01479-4 · Cited by 912
Calcium-activated neutral protease (calpain) system: structure, function, and regulation.
Croall, D. E., & DeMartino, G. N. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.3.813 · Cited by 833
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Self-citationHuntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Structure and physiological function of calpains
SORIMACHI, H., ISHIURA, S., & SUZUKI, K. (1997) · Biochemical Journal · doi:10.1042/bj3280721 · Cited by 707
Calpain: new perspectives in molecular diversity and physiological‐pathological involvement
Saido, T. C., Sorimachi, H., & Suzuki, K. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.11.8070630 · Cited by 660
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Self-citationNeurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Goldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 581
Self-citationWellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562
Self-citationMartindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., Singaraja, R., Kazemi-Esfarjani, P., Devon, R., Kim, S. U., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-150 · Cited by 485
Self-citationTang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Bezprozvanny, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 481
Self-citationThe calpain family and human disease
Huang, Y., & Wang, K. K. W. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02049-4 · Cited by 472
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Lunkes, A., Lindenberg, K. S., Ben-Haı̈em, L., Weber, C., Devys, D., Landwehrmeyer, G. B., Mandel, J.-L., & Trottier, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00602-0 · Cited by 416
Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease
Wellington, C. L., Ellerby, L. M., Gutekunst, C.-A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y.-Z., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07862.2002 · Cited by 399
Self-citationKim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion
Chen, M., He, H., Zhan, S., Krajewski, S., Reed, J. C., & Gottlieb, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103701200 · Cited by 396
Cutting to the chase: calpain proteases in cell motility
Glading, A., Lauffenburger, D. A., & Wells, A. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02179-1 · Cited by 389
Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001475200 · Cited by 358
Self-citationCalpain Activation in Huntington's Disease
Gafni, J., & Ellerby, L. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04842.2002 · Cited by 331
Self-citationNeuronal loss in layers V and VI of cerebral cortex in Huntington's disease
Hedreen, J. C., Peyser, C. E., Folstein, S. E., & Ross, C. A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90583-f · Cited by 319
Roberts-Lewis, J., Savage, M., Marcy, V., Pinsker, L., & Siman, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03934.1994 · Cited by 316
The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., & Hayden, M. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1097 · Cited by 313
Self-citationSun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Direct Cleavage by the Calcium-activated Protease Calpain Can Lead to Inactivation of Caspases
Chua, B. T., Guo, K., & Li, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5131 · Cited by 294
Kegel, K. B., Meloni, A. R., Yi, Y., Kim, Y. J., Doyle, E., Cuiffo, B. G., Sapp, E., Wang, Y., Qin, Z.-H., Chen, J. D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103946200 · Cited by 287
Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death
Lankiewicz, S., Marc Luetjens, C., Truc Bui, N., Krohn, A. J., Poppe, M., Cole, G. M., Saido, T. C., & Prehn, J. H. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.17064 · Cited by 260
Kennedy's Disease: Caspase Cleavage of the Androgen Receptor Is a Crucial Event in Cytotoxicity
Ellerby, L. M., Hackam, A. S., Propp, S. S., Ellerby, H. M., Rabizadeh, S., Cashman, N. R., Trifiro, M. A., Pinsky, L., Wellington, C. L., Salvesen, G. S., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720185.x · Cited by 245
Self-citationRegional calpain and caspase-3 proteolysis of α-spectrin after traumatic brain injury
Pike, B. R., Zhao, X., Newcomb, J. K., Posmantur, R. M., Wang, K. K., & Hayes, R. L. (1998) · NeuroReport · doi:10.1097/00001756-199808030-00002 · Cited by 204
Mutant Huntingtin Enhances Excitotoxic Cell Death
Zeron, M. M., Chen, N., Moshaver, A., Ting-Chun Lee, A., Wellington, C. L., Hayden, M. R., & Raymond, L. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0909 · Cited by 197
Self-citationNuclear Targeting of Mutant Huntingtin Increases Toxicity
Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0773 · Cited by 191
Nuclear Accumulation of Truncated Atrophin-1 Fragments in a Transgenic Mouse Model of DRPLA
Schilling, G., Wood, J. D., Duan, K., Slunt, H. H., Gonzales, V., Yamada, M., Cooper, J. K., Margolis, R. L., Jenkins, N. A., Copeland, N. G., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80839-9 · Cited by 181
Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
Self-citationHuntingtin contains a highly conserved nuclear export signal
Xia, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg156 · Cited by 180
Sapp, E., Ge, P., Aizawa, H., Bird, E., Penney, J., Young, A. B., Vonsattel, J.-P., & Difiglia, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00427-7 · Cited by 161
Cleavage of Atrophin-1 at Caspase Site Aspartic Acid 109 Modulates Cytotoxicity*
Ellerby, L., Andrusiak, R. L., Wellington, C., Hackam, A., Propp, S. S., Wood, J., Sharp, A., Margolis, R., Ross, C., Salvesen, G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8730 · Cited by 125
Self-citationCharacterization and Expression of Calpain 10
Ma, H., Fukiage, C., Kim, Y. H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100603200 · Cited by 115
Panov, A. V., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00585-4 · Cited by 104
Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7.
Kaytor, M., Duvick, L., Skinner, P., Koob, M. D., Ranum, L., & Orr, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1657 · Cited by 104
Huntington, G. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.1.109 · Cited by 102
Nucifora, F. C., Ellerby, L., Wellington, C. L., Wood, J. D., Herring, W. J., Sawa, A., Hayden, M. R., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211224200 · Cited by 93
Self-citationHackam, A. S. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.25 · Cited by 86
Proteolysis of the N-Methyl-d-Aspartate Receptor by Calpain in Situ
Guttmann, R. P., Sokol, S. A., Baker, D. L., Simpkins, K. L., Dong, Y., & Lynch, D. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036962 · Cited by 83
Shields, D. C., Tyor, W. R., Deibler, G. E., Hogan, E. L., & Banik, N. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5768 · Cited by 77
Kamei, M., Webb, G. C., Young, I. G., & Campbell, H. D. (1998) · Genomics · doi:10.1006/geno.1998.5395 · Cited by 46
Ray, S. K., Wilford, G. G., Ali, S. F., & Banik, N. L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05202.x · Cited by 32
Cited by
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E. K., Saiki, S., Siddiqi, F. H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.79 · Cited by 800
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Metadata
- Authors
- Gafni, J., Hermel, E., Young, J. E., Wellington, C. L., Hayden, M. R., & Ellerby, L. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 279
- Issue
- 19
- Pages
- 20211-20220
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2067155896
- Cited by
- 281
- References
- 56
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.